11 September 2026 in SSRN Electronic Journal
Introduction: Transcutaneous auricular vagus nerve stimulation is a non-invasive neuromodulation technique that targets the vagus nerve by applying mild electrical pulses to the ear. taVNS has been assessed for effects on mood, cognitive performance, and as a possible treatment for many medical conditions, but its neurochemical effects remain unclear.Methods: We acquired ultrahigh-field, 7 Tesla magnetic resonance spectroscopy in a sample of 30 healthy males and females at baseline and approximately 20- and 90-minutes after taVNS ended. Neurochemical changes in the anterior and posterior cingulate cortices, superior temporal gyrus, and ventromedial and dorsolateral prefrontal cortices were measured between taVNS and a sham condition before stimulation (baseline) and during two post-stimulation scans.Results: Immediately following stimulation, concentrations of GABA, glutamate, and myo-inositol were decreased compared to sham in the dorsolateral prefrontal cortex. Compared to sham, taVNS had no significant effect on any other neurochemical, in any other brain region, approximately one hour after the conclusion of stimulation.Conclusions: We found that a single 20-minute session of taVNS was associated with greater decreases from before to after taVNS in GABA, glutamate, and myo-inositol in the dorsolateral prefrontal cortex compared to sham, with no significant effects on any other neurochemical or brain region. Rather than a shift in excitatory-inhibitory balance, the concurrent decrease of glutamate and GABA suggests that synaptic activity in the dorsolateral prefrontal cortex was reduced by parasympathetic nervous system input. Meanwhile, decreased myo-inositol may reflect decreases in immune response or greater activity of monoamines with taVNS.